H.R. 1294 (105th): To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.

Introduced:

Apr 10, 1997
105th Congress, 1997–1998

Status:
Died in a previous Congress

This bill was introduced on April 10, 1997, in a previous session of Congress, but was not enacted.

Sponsor:

Patrick Kennedy

Representative for Rhode Island's 1st congressional district

Democrat

Text:

Read Text »
Last Updated: Apr 10, 1997
Length: 3 pages

About the bill

Read CRS Summary >

History

Apr 10, 1997
 
Introduced

This is the first step in the legislative process.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Details

Cosponsors
none
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 1119 (Related)
National Defense Authorization Act for Fiscal Year 1998

Enacted — Signed by the President
Nov 18, 1997

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: